3-Bromo-2-fluorophenylmethanol

We are 3-Bromo-2-fluorophenylmethanol CAS:261723-32-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 3-Bromo-2-fluorophenylmethanol
Other Name:
3-Bromo-2-fluorophenylmethanol
(3-Bromo-2-fluorophenyl)methanol
3-Bromo-2-fluorobenzyl alcohol
Bromofluorophenylmethanol
3-bromo-2-fluoro Benzenemethanol
CAS No: 261723-32-4
MF: C7H6BrFO
MW: 205.02400
Density: 1.658g/cm3
Boiling point: 263.232ºC at 760 mmHg
Melting point: NA
Flash point: 112.999ºC
Refractive index: 1.567
UN Number: UN2811
UN Proper Shipping Name: ADR/RID: TOXIC SOLID, ORGANIC, N.O.S.
Transport hazard class: 6.1
Packing group: III
 
Specification
Assay: ≥99.0%
Water: ≤0.50%
 
Application
Organic synthesis intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-Bromo-2-fluorophenylmethanol


Related News: Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.267243-68-5 The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.2-metoxi-3-nitropiridina CAS:20265-35-4 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.5- (Difluorometoxi) -2-mercapto-1H-bencimidazol CAS:97963-62-7 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.

Related Products
Product Name
(2R)-3,3-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid View Details
1H-PYRROLO[2,3-B]PYRIDIN-5-OL Cas:98549-88-3 View Details
3-(9-phenyl-carbazol-3-yl)-9H-carbazole View Details
Acetyl Tetrapeptide-2 manufacturer basic Orange 31 Cas:97404-02-9 manufacturer 5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione manufacturer 3-Bromo-4-chloropyridine manufacturer 1-Naphthyl acetonitrile manufacturer